Generic Drug Application Submission Downturn Continued In June

 
• By Derrick Gingery

Approvals also plummeted, but US FDA remains on a record-breaking pace.

FDA entrance sign 2016
The 48 ANDA submissions reported in June were the lowest monthly total seen in FY 2019. • Source: File photo

More from Generics

More from Biosimilars & Generics